Enterprise Europe Network (Profile:BRKR20210924001)
Company’s medical microrobot system is composed of magnetic guidewire-microrobot, current control unit, user interface software, and electromagnetic coils. Electromagnetic coils which are fixed under patient bed, are designed to be compatible with conventional medical image equipment such as X-ray according to the clinicians’ feedback. This allows the medical team and the operator to easily approach the patient when in need. These coils can be uninstalled/unfixed after use, and kept secured separately. Once the equipment has been removed, the surgery room is ready to be used for other general procedures. Hence, there is no need for an exclusive surgery room.
The company is prioritizing medical microrobot system for interventional treatment. However, its applicable in the field of active target therapy. With the identical principle, different types of microrobots could deliver therapeutic agents to a specific lesion inside the body using 3D magnetic field control system.
Conventional methods of drug treatment include oral intake and injection. These methods face major weakness which the drug also affects the normal tissues simultaneously. As result, the amount of drug delivered to target area is often inadequate, along with risk of side effects on unwanted areas. With magnetic microrobots and 3D magnetic field control system for its manipulation, it is able to deliver drugs to specific lesion for full efficiency.
The company is one of the leading entrepreneurs in developing medical microrobot system. Core members have the largest number of patents applied for the past 5 years, with more than 10 years of experience in microrobot research and for its use as medicine. Research papers are one of the top influential papers in the world with publications in Science Robotics, Science Advances, Advanced Materials, Soft Robotics, Micromachines and more.
Company is looking for partnership with any organization, research institutes, hospitals, and others that are interested in utilizing microrobot as the next generation medical device. Partner should be able and willing to carry out preclinical studies and clinical trials under a subcontracting agreement.
For more information please contact Enterprise Europe Network Latvia.